Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen) [NA]
Update on the ProScreen randomized trial evaluating early detection of clinically significant prostate cancer; the study is actively enrolli…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Clinical Utility of ClarityDX Prostate [NA]
This clinical trial update indicates that Nanostics is recruiting participants for a study evaluating the clinical utility of the ClarityDX …
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate
Clinical trial OLIGOS is studying the impact of treatment on the primary tumor in patients with newly diagnosed oligometastatic prostate can…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real-World Study
A real-world study assessing the effectiveness, safety, and economic impact of goserelin microspheres for injection and goserelin sustained-…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression [Phase 3]
A Phase 3 clinical trial is evaluating creatine supplementation with resistance training to preserve muscle mass in metastatic prostate canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery [NA]
This clinical trial update notes a prospective evaluation of the Cornerstone Robotics Sentire Surgical System in major gastrointestinal and …
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: TH1902 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for TH1902 in patients with advanced solid tumors. The study is currently active/not recruiting and …
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Randomized Trial of HIFU vs. Cryo for Prostate Cancer [NA]
A randomized trial comparing High-Intensity Focused Ultrasound (HIFU) versus cryoablation for prostate cancer has completed.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Ongoing University of Alberta-sponsored LONGEVITI study, LIVInG With chrONic Cancer TrEatments, is currently recruiting to evaluate cancer t…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide [Phase 2]
A Phase 2 study comparing docetaxel versus cabazitaxel in patients with metastatic prostate cancer after progression on abiraterone or enzal…
-
CLINICAL_TRIALS other · 2025-04-13Clinical Trial Update: Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. [Phase 3]
A Phase III clinical trial evaluating INR101 injection for PET/CT imaging in prostate cancer is not yet recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-04-13Clinical Trial Update: 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer [Phase 2]
Phase 2 trial evaluating 18F-PSMA PET/MRI for diagnosing clinically significant prostate cancer has been withdrawn from ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating hydroxychloroquine to increase PAR-4 tumor suppressor levels in oligometastatic/prostate cancer; study completed wi…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC [Phase 1]
Phase 1 clinical trial evaluating the safety and preliminary efficacy of Universal PSMA CAR-T cells in patients with refractory metastatic c…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer
A completed clinical trial evaluating whether intratumoral heterogeneity on PSMA and FDG PET/CT imaging can predict invasion and prognosis i…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy [EARLY_Phase 1]
A Phase 1 study evaluating systemic light exposure to prevent frailty in older patients with prostate cancer receiving hormonal therapy has …
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment [Phase 3]
This document reports a multicenter Phase III clinical trial evaluating INR101 Injection for PET/CT imaging in men with suspected recurrent …
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer [NA]
This clinical trial entry describes a study using 3-Tesla MRI to find tumors in patients with known or suspected prostate cancer; the study …
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model
A completed clinical trial from Abramson Cancer Center at Penn Medicine evaluated an alternative genetics-based cancer care delivery model, …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III) [NA]
HYPOSTAT-III is a clinical trial evaluating hypofractionated radiosurgery for localized prostate cancer, and the study is currently not recr…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen [Phase 1]
The document reports the completion of a Phase 1 clinical trial evaluating [177Lu]Lu-BQ7876 for targeting PSMA in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413 [Phase 1]
A Phase 1 trial evaluating a Technetium-99m labeled PSMA-targeted radiopharmaceutical, BQ0413, for molecular imaging in prostate cancer. The…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 [Phase 1]
Phase 1 study evaluating molecular imaging of gastrin-releasing peptide receptors using Technetium-99m-labeled DB8 in prostate cancer and br…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Evaluation of Prostate Cancer Margins
Completed clinical trial evaluating margins in prostate cancer sponsored by Intuitive Surgical.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial [NA]
This clinical trial update covers the MAPS trial, which investigates MRI-guided, dose-escalated salvage radiotherapy after prostatectomy, wi…